Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E.

[1]  T. Negri,et al.  Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by β sarcoglycan mutations , 2000, Journal of medical genetics.

[2]  J. Sanes,et al.  ε-Sarcoglycan Replaces α-Sarcoglycan in Smooth Muscle to Form a Unique Dystrophin-Glycoprotein Complex* , 1999, The Journal of Biological Chemistry.

[3]  K. Campbell,et al.  Biochemical Characterization of the Epithelial Dystroglycan Complex* , 1999, The Journal of Biological Chemistry.

[4]  H. Hama,et al.  Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. , 1999, Human molecular genetics.

[5]  K. Campbell,et al.  Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy , 1999, Cell.

[6]  J. Sanes,et al.  Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex , 1999, The Journal of cell biology.

[7]  E. Hoffman,et al.  Heart involvement in muscular dystrophies due to sarcoglycan gene mutations , 1999, Muscle & nerve.

[8]  C. Leveille,et al.  Molecular Pathogenesis of Muscle Degeneration in the δ-Sarcoglycan-Deficient Hamster , 1998 .

[9]  K. Campbell,et al.  The sarcoglycan complex in limb-girdle muscular dystrophy. , 1998, Current opinion in neurology.

[10]  K. Campbell,et al.  Dystroglycan in development and disease. , 1998, Current opinion in cell biology.

[11]  John A. Faulkner,et al.  Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice , 1998, The Journal of cell biology.

[12]  R. Wollmann,et al.  γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin , 1998, The Journal of cell biology.

[13]  K. Campbell,et al.  Caveolin‐3 is not an integral component of the dystrophin glycoprotein complex , 1998, FEBS letters.

[14]  K. Campbell,et al.  Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer. , 1998, Molecular cell.

[15]  C. Bönnemann,et al.  LGMD 2E in Tunisia is caused by a homozygous missense mutation in β-sarcoglycan exon 3 , 1998, Neuromuscular Disorders.

[16]  J. Towbin,et al.  The role of cytoskeletal proteins in cardiomyopathies. , 1998, Current opinion in cell biology.

[17]  F. Quétier,et al.  β-Sarcoglycan: genomic analysis and identification of a novel missense mutation in the LGMD2E Amish isolate , 1998, Neuromuscular Disorders.

[18]  L. Kunkel,et al.  Human ϵ‐sarcoglycan is highly related to α‐sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene 1 , 1998, FEBS letters.

[19]  J. Sanes,et al.  ε-Sarcoglycan, a Broadly Expressed Homologue of the Gene Mutated in Limb-Girdle Muscular Dystrophy 2D* , 1997, The Journal of Biological Chemistry.

[20]  Y. Murakami,et al.  Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Campbell,et al.  Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption , 1997, The Journal of cell biology.

[22]  J. Sanes,et al.  Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.

[23]  E. Engvall,et al.  Mouse adhalin: primary structure and expression during late stages of muscle differentiation in vitro. , 1997, Biochemical and biophysical research communications.

[24]  K. Campbell,et al.  Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. , 1997, Human molecular genetics.

[25]  K. Campbell,et al.  Muscular dystrophies and the dystrophin-glycoprotein complex. , 1997, Current opinion in neurology.

[26]  L. Kunkel,et al.  Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). , 1996, Human molecular genetics.

[27]  J. Beckmann,et al.  β–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12 , 1995, Nature Genetics.

[28]  L. Kunkel,et al.  β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex , 1995, Nature Genetics.

[29]  A. Nishikawa,et al.  Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. , 1995, Journal of biochemistry.

[30]  S. Noguchi,et al.  Dystrophin-associated proteins in muscular dystrophy. , 1995, Human molecular genetics.

[31]  B. Davidson,et al.  Expression of Escherichia coli β-Galactosidase and Rat HPRT in the CNS of Macaca mulatta Following Adenoviral Mediated Gene Transfer , 1994, Experimental Neurology.

[32]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin). , 1993, The Journal of biological chemistry.

[33]  J. Ervasti,et al.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin , 1993, The Journal of cell biology.

[34]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Small,et al.  Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle , 1993, The Journal of cell biology.

[36]  G. Lyons,et al.  Localization of dystrophin gene transcripts during mouse embryogenesis , 1992, The Journal of cell biology.

[37]  K. Campbell,et al.  Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice , 1991, The Journal of cell biology.

[38]  J. Ervasti,et al.  Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.

[39]  J. Ervasti,et al.  Purification of dystrophin from skeletal muscle. , 1991, The Journal of biological chemistry.

[40]  K. Jaffe,et al.  Symptoms of upper gastrointestinal dysfunction in Duchenne muscular dystrophy: case-control study. , 1990, Archives of physical medicine and rehabilitation.

[41]  J. O. Olson,et al.  Gastric hypomotility in Duchenne's muscular dystrophy. , 1988, The New England journal of medicine.

[42]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[43]  E. Sonnenblick,et al.  Microvascular Spasm in the Cardiomyopathic Syrian Hamster: A Preventable Cause of Focal Myocardial Necrosis , 1982, Circulation.

[44]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[45]  S. Froehner,et al.  Syntrophins: modular adapter proteins at the neuromuscular junction and the sarcolemma. , 1997, Society of General Physiologists series.